| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Atlas Venture Fund XI, L.P. | 10%+ Owner | $11.4M | Mar 30, 2021 | ||
| David P. Bonita | Director | $489K | Jun 7, 2024 | ||
| Orbimed Advisors Llc | Director | $489K | Aug 4, 2023 | ||
| Maria Koehler | Director | Jun 7, 2024 | |||
| Sergio Santillana | Chief Medical Officer | Jan 3, 2023 | |||
| Jotin Marango | CFO & Head of Corp. Dev. | Feb 1, 2024 | |||
| Jeffrey Ecsedy | Chief Development Officer | Feb 1, 2024 | |||
| Mark Manfredi | President & CEO, Director | Feb 1, 2024 | |||
| Otello Stampacchia | Director | Jun 7, 2024 | |||
| Iain D. Dukes | Director | Jun 7, 2024 | |||
| Owen Hughes | Director | Jun 7, 2024 | |||
| Richard Wooster | Director | Jun 7, 2024 | |||
| Francisco Oliveira | Principal Accounting Officer | Feb 18, 2022 | |||
| Xiaoyan Michelle Zhang | Chief Scientific Officer | Jan 3, 2023 | |||
| Caroline Germa | Chief Medical Officer | Mar 1, 2024 | |||
| Maude Tessier | Chief Business Officer | Feb 2, 2022 | |||
| Jean Francois Formela | Director | Jun 7, 2024 | |||
| Ronald C. Renaud JR | Director | Jun 9, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|